{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T16:58:06Z","timestamp":1776531486030,"version":"3.51.2"},"reference-count":54,"publisher":"Informa UK Limited","issue":"4","funder":[{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Hematology"],"published-print":{"date-parts":[[2018,4,21]]},"DOI":"10.1080\/10245332.2017.1385192","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T11:59:58Z","timestamp":1507809598000},"page":"194-200","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Recommendations on the use of ruxolitinib for the treatment of myelofibrosis"],"prefix":"10.1080","volume":"23","author":[{"given":"Timothy","family":"Devos","sequence":"first","affiliation":[{"name":"Department of Hematology, University Hospitals Leuven, Leuven, Belgium"},{"name":"Laboratory of Experimental Transplantation, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"Selleslag","sequence":"additional","affiliation":[{"name":"Department of Hematology, Algemeen Ziekenhuis Sint-Jan, Bruges, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Zach\u00e9e","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Network Antwerp, Antwerp, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fleur Samantha","family":"Benghiat","sequence":"additional","affiliation":[{"name":"Department of Hemato-Oncolocy, Erasme Hospital, Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2017,10,12]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2011.11.001"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2208-2"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1586\/17474086.2013.827413"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23703"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.229"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2017.1001.1050"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2006.12.002"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-170449"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-09-245837"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1179\/2295333714Y.0000000097"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.09.005"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2016.013268"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2016.1146950"},{"key":"CIT0015","unstructured":"European Medicines Agency. Committee for Medicinal Products for Human Use assessment report \u2013 Jakavi. [cited 2017 Mar 24]. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Public_assessment_report\/human\/002464\/WC500133226.pdf"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110556"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110557"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.2217\/fon.14.272"},{"key":"CIT0019","doi-asserted-by":"crossref","unstructured":"Verstovsek S, Gupta V, Gotlib J, et\u00a0al. Pooled overall survival analysis of 5-year data from the COMFORT-I and COMFORT-II trials of ruxolitinib for the treatment of myelofibrosis (Abstract #3110). 58th Meeting & Exposition of the American Society of Hematology, San Diego, CA, United States; 2\u20136 December, 2016.","DOI":"10.1182\/blood.V128.22.3110.3110"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.233"},{"key":"CIT0021","unstructured":"Institut National d'Assurance Maladie-Invalidit\u00e9 (INAMI). Sp\u00e9cialit\u00e9s pharmaceutiques \u2013 Liste \u2013 Chapter IV - 01\/05\/2017 \u2013 Lijst \u2013 Farmaceutische specialiteiten. [cited 2017 May 3]. Available from: http:\/\/www.inami.fgov.be\/SiteCollectionDocuments\/liste-specialites-chapter4-20170501.pdf"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2016.1195501"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.143677"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13379"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2016.0169"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.283"},{"key":"CIT0027","unstructured":"Novartis Oncology. Paper version of the MPN10 Symptom Tracker; MPN10 Know your score. [cited 2017 May 3]\/ Available from: http:\/\/jakavimicrosite.prod.novartis.episerverhosting.com\/globalassets\/site-components12\/oncology\/micro-jakavi\/images\/g-2014-inc-mpn_mpn10-symptom-form1.pdf"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.802318"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-03-633404"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-530865"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-695957"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.119"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.76"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-6-81"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-6-79"},{"key":"CIT0036","unstructured":"Centre Belge d'Information Pharmacoth\u00e9rapeutique (CBIP). R\u00e9pertoire comment\u00e9 des m\u00e9dicaments. [cited 2017 Mar 24]. Available from: http:\/\/www.cbip.be\/fr\/chapters\/14?frag=13227&trade_family=13821"},{"key":"CIT0037","unstructured":"European Medicines Agency (EMA). Jakavi: EPAR \u2013 Product Information. Annex 1: Summary of product characteristics. [cited 2017 Mar 2017]. Available: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/002464\/WC500133223.pdf. Last updated on Januray 25, 2017"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.77"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1177\/0091270011405663"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1002028"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S53348"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.151449"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-015-0021-2"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12985"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-07-575373"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12375"},{"issue":"21","key":"CIT0047","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1182\/blood.V122.21.1586.1586","volume":"122","author":"Tabarroki A","year":"2013","journal-title":"Blood"},{"issue":"22","key":"CIT0048","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1182\/blood.V128.22.3107.3107","volume":"128","author":"Foltz L","year":"2016","journal-title":"Blood"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2014.84"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.115840"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-10-531103"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24572"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-016-2084-1"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-485888"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10245332.2017.1385192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T14:39:19Z","timestamp":1599316759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10245332.2017.1385192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,12]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4,21]]}},"alternative-id":["10.1080\/10245332.2017.1385192"],"URL":"https:\/\/doi.org\/10.1080\/10245332.2017.1385192","relation":{},"ISSN":["1607-8454"],"issn-type":[{"value":"1607-8454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yhem20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yhem20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-10-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}